Chengdu Easton Biopharmaceuticals Co., Ltd.
SSE:688513.SS
40.64 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| 238.234 | 226.574 | 246.521 | 232.428 | 178.162 | 108.612 | 135.02 | 64.366 | 57.317 | 37.619 | 29.233 | 14.731 |
| Depreciation & Amortization
| 82.836 | 74.722 | 58.349 | 32.605 | 32.977 | 27.5 | 25.354 | 23.706 | 21.867 | 19.807 | 12.602 | 8.484 |
| Deferred Income Tax
| 0 | 0.735 | 4.194 | -3.315 | -5.313 | 0.522 | 0.534 | -1.538 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0.255 | 0 | 0 | 0 | 28.275 | 1.5 | 12.994 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -67.195 | -7.526 | -132.405 | -77.054 | -47.83 | -21.888 | 4.885 | -15.626 | 17.599 | -8.694 | -0.148 | 0 |
| Accounts Receivables
| -112.437 | -75.724 | -51.531 | -181.323 | -121.687 | -48.298 | -42.628 | -21.508 | 0 | -5.801 | -0.585 | 0 |
| Inventory
| -34.803 | -22.74 | -39.502 | -21.553 | -25.584 | -11.738 | -0.529 | -12.484 | -5.463 | -3.813 | -0.226 | 0 |
| Accounts Payables
| 0 | 90.202 | -45.566 | 129.137 | 104.755 | 37.627 | 47.508 | 19.904 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 80.045 | 0.735 | 4.194 | -3.315 | -5.313 | 0.522 | 5.414 | -3.142 | 23.062 | 0.919 | 0.664 | 0 |
| Other Non Cash Items
| 9.366 | -19.508 | -20.52 | -40.382 | -6.785 | -1.191 | 1.529 | 13.254 | 9.275 | 1.835 | 5.025 | 4.902 |
| Operating Cash Flow
| 263.24 | 275.252 | 151.945 | 147.597 | 156.525 | 141.83 | 166.788 | 85.7 | 106.058 | 50.567 | 46.712 | 28.117 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -117.424 | -175.262 | -339.328 | -256.29 | -198.809 | -95.414 | -76.633 | -23.021 | -17.826 | -35.433 | -22.037 | -76.109 |
| Acquisitions Net
| 0 | 0 | 0.331 | -160.612 | 0.099 | 0.05 | 0 | 0.039 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -1.5 | -34.5 | -120 | -4,049 | -2,266.99 | -1,224.63 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 73.794 | 4,209.612 | 1,707.25 | 1,231.883 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 315.555 | -200.413 | -20.5 | 145.704 | 1.824 | 0.12 | 1.826 | 8.914 | -2.566 | 1.79 | 13.653 | 16.532 |
| Investing Cash Flow
| 196.631 | -410.175 | -405.702 | -110.587 | -756.626 | -87.991 | -74.807 | -14.107 | -20.392 | -33.643 | -8.384 | -59.577 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -103.923 | 143.523 | 50 | -20 | 40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | -27.879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -74.108 | -71.077 | -93.67 | -36.027 | -0.696 | -22.5 | 0 | -22.5 | 0 | 0 | -2.529 | -2.375 |
| Other Financing Activities
| -84.234 | 8.225 | 83.366 | 0 | 1,212.055 | 8.642 | 0 | -4 | 69.72 | 0.847 | -10.853 | 17.019 |
| Financing Cash Flow
| -262.265 | 80.671 | 39.696 | -56.397 | 1,251.359 | -13.858 | 0 | -26.5 | 69.72 | 0.847 | -13.382 | 14.644 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0.032 | -0.067 | 0.023 | -0.005 | -0.025 | 0.025 | 0.033 | -0.091 | 0.05 | 0 | 0 | 0 |
| Net Change In Cash
| 197.638 | -54.319 | -214.038 | -19.392 | 651.232 | 40.006 | 92.013 | 45.002 | 155.436 | 17.772 | 24.946 | -16.816 |
| Cash At End Of Period
| 965.179 | 767.541 | 821.859 | 1,035.897 | 1,055.289 | 404.057 | 364.051 | 272.038 | 227.036 | 65.71 | 47.938 | 22.992 |